This relationship between insulin signaling and other CMD is supported by an estimated 61% of T2D cases simultaneously correlate with obesity, therefore making obesity a strong risk factor for the development of T2D (Zheng et al., 2018). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.